Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Murdoch

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
The Journal of Allergy and Clinical Immunology|October 1, 1988
Prostaglandin D2 and histamine release in cold urticaria unaccompanied by evidence of platelet activationA D Ormerod, A Kobza Black, J Dawes, et al.
Pulmonary Pharmacology & Therapeutics|April 3, 2003
Does a single dose of the phosphodiesterase 4 inhibitor, cilomilast (15 mg), induce bronchodilation in patients with chronic obstructive pulmonary disease?D C Grootendorst, S A Gauw, R Baan, et al.
The American Review of Respiratory Disease|May 1, 1988
A comparison of mediator and catecholamine release between exercise- and hypertonic saline-induced asthmaN G Belcher, R D Murdoch, N Dalton, et al.
Photodermatology, Photoimmunology & Photomedicine|May 15, 2009
Delayed ultraviolet erythema not suppressed by oral prednisolone: a randomized crossover studyF M Muller, R S Dawe, R D Murdoch, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 23, 2015
The improved efficacy of a fixed-dose combination of fluticasone furoate and levocabastine relative to the individual components in the treatment of allergic rhinitisR D Murdoch, P Bareille, D Ignar, et al.
Pulmonary Pharmacology & Therapeutics|June 22, 1999
Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinicT J Torphy, M S Barnette, D C Underwood, et al.
Journal of Clinical Pharmacology|September 11, 2001
An overview of the pharmacokinetics of cilomilast (Ariflo), a new, orally active phosphodiesterase 4 inhibitor, in healthy young and elderly volunteersB D Zussman, L J Benincosa, D M Webber, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 6, 2006
Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challengeE M Erin, A S Zacharasiewicz, G C Nicholson, et al.
Pharmacotherapy|June 13, 2001
Bioavailability of the oral selective phosphodiesterase 4 inhibitor cilomilastB D Zussman, C C Davie, J Kelly, et al.
The European Respiratory Journal|October 26, 2007
Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjectsR A Brown, G W Clarke, C L Ledbetter, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The Journal of Allergy and Clinical Immunology|October 1, 1988
Prostaglandin D2 and histamine release in cold urticaria unaccompanied by evidence of platelet activationA D Ormerod, A Kobza Black, J Dawes, et al.
Pulmonary Pharmacology & Therapeutics|April 3, 2003
Does a single dose of the phosphodiesterase 4 inhibitor, cilomilast (15 mg), induce bronchodilation in patients with chronic obstructive pulmonary disease?D C Grootendorst, S A Gauw, R Baan, et al.
The American Review of Respiratory Disease|May 1, 1988
A comparison of mediator and catecholamine release between exercise- and hypertonic saline-induced asthmaN G Belcher, R D Murdoch, N Dalton, et al.
Photodermatology, Photoimmunology & Photomedicine|May 15, 2009
Delayed ultraviolet erythema not suppressed by oral prednisolone: a randomized crossover studyF M Muller, R S Dawe, R D Murdoch, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 23, 2015
The improved efficacy of a fixed-dose combination of fluticasone furoate and levocabastine relative to the individual components in the treatment of allergic rhinitisR D Murdoch, P Bareille, D Ignar, et al.
Pulmonary Pharmacology & Therapeutics|June 22, 1999
Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinicT J Torphy, M S Barnette, D C Underwood, et al.
Journal of Clinical Pharmacology|September 11, 2001
An overview of the pharmacokinetics of cilomilast (Ariflo), a new, orally active phosphodiesterase 4 inhibitor, in healthy young and elderly volunteersB D Zussman, L J Benincosa, D M Webber, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 6, 2006
Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challengeE M Erin, A S Zacharasiewicz, G C Nicholson, et al.
Pharmacotherapy|June 13, 2001
Bioavailability of the oral selective phosphodiesterase 4 inhibitor cilomilastB D Zussman, C C Davie, J Kelly, et al.
The European Respiratory Journal|October 26, 2007
Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjectsR A Brown, G W Clarke, C L Ledbetter, et al.
Pageof 3